By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Beta-blocker > Bisoprolol

Bisoprolol

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
6 Min Read
SHARE
4 min read|729 words

What is Bisoprolol?

Bisoprolol is a prescription medication belonging to a class of drugs called beta-blockers, specifically a selective beta-1 adrenergic receptor blocker. It is primarily used to treat high blood pressure (hypertension) and heart failure, helping to reduce the workload on the heart and improve cardiovascular function. This medication is available in tablet form and requires a prescription from a healthcare provider.

Uses

Bisoprolol is approved for several cardiovascular conditions:

High blood pressure (hypertension): Bisoprolol helps lower blood pressure by reducing heart rate and the force of heart contractions, making it easier for blood to flow through the vessels.

Heart failure: In patients with chronic heart failure, bisoprolol can improve symptoms and reduce the risk of hospitalization by allowing the heart to work more efficiently over time.

Submit Your Paper
GMJ_Submit_Banner

Coronary artery disease: The medication may be prescribed to reduce chest pain (angina) and lower the risk of heart attacks in patients with coronary artery disease.

Post-heart attack care: Bisoprolol can be used as part of long-term treatment following a heart attack to improve survival rates and prevent future cardiac events.

Arrhythmia management: In some cases, bisoprolol may help control irregular heart rhythms by regulating the electrical activity of the heart.

How it works

Bisoprolol works by selectively blocking beta-1 adrenergic receptors, which are primarily found in the heart. By blocking these receptors, the medication prevents the effects of stress hormones like adrenaline and noradrenaline on the heart. This results in a slower heart rate, reduced force of heart contractions, and decreased blood pressure, ultimately reducing the heart’s oxygen demand and workload.

Side effects

Common side effects include:

  • Fatigue and tiredness
  • Dizziness or lightheadedness
  • Headache
  • Cold hands and feet
  • Nausea
  • Diarrhea or constipation
  • Sleep disturbances or unusual dreams
  • Reduced exercise tolerance

Serious side effects requiring immediate medical attention:

  • Severe breathing difficulties or wheezing
  • Chest pain or irregular heartbeat
  • Severe dizziness or fainting
  • Signs of heart failure (swelling in legs, ankles, or feet)
  • Severe allergic reactions (rash, swelling, difficulty breathing)

Warnings and precautions

Asthma and respiratory conditions: Bisoprolol should be used with extreme caution in patients with asthma, chronic obstructive pulmonary disease (COPD), or other breathing disorders, as it may worsen these conditions.

Diabetes: The medication can mask symptoms of low blood sugar and may affect glucose control, requiring careful monitoring in diabetic patients.

Sudden discontinuation: Bisoprolol should never be stopped abruptly, as this can lead to dangerous rebound effects including severe increases in blood pressure and risk of heart attack.

Pregnancy and breastfeeding: The safety of bisoprolol during pregnancy has not been fully established, and it should only be used when potential benefits outweigh risks. The medication can pass into breast milk.

Liver and kidney function: Patients with severe liver or kidney disease may require dose adjustments, as these organs are involved in processing and eliminating the medication from the body.

Interactions

Calcium channel blockers (verapamil, diltiazem): Can increase the risk of dangerously slow heart rate and low blood pressure when combined with bisoprolol.

Insulin and diabetes medications: Bisoprolol may enhance the blood sugar-lowering effects and mask symptoms of hypoglycemia.

NSAIDs (ibuprofen, naproxen): These pain relievers can reduce the blood pressure-lowering effectiveness of bisoprolol.

Digoxin: The combination may increase the risk of slow heart rate and requires careful monitoring.

Clonidine: If both medications need to be discontinued, bisoprolol should be stopped first to avoid dangerous blood pressure spikes.

Rifampin: This antibiotic can increase the metabolism of bisoprolol, potentially reducing its effectiveness.

Alcohol: Can enhance the blood pressure-lowering effects and increase dizziness and drowsiness.

Epinephrine: Bisoprolol may reduce the effectiveness of epinephrine in treating severe allergic reactions.

Check interactions with the GMJ Interaction Checker

Dosage

For adults with high blood pressure, the typical starting dose is 5 mg once daily, which may be increased to 10 mg or 20 mg daily based on response and tolerability. For heart failure, treatment usually begins with 1.25 mg once daily, with gradual increases over several weeks to a target dose as determined by the healthcare provider. The maximum recommended daily dose is typically 20 mg. Dosage adjustments may be necessary for patients with liver or kidney problems, and all dosing decisions should be made by a qualified healthcare provider based on individual patient factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Bisoprolol." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/bisoprolol/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Approves 47 New Pharmaceutical Manufacturing and Wholesale Dealer Licences in Latest MHRA Review

UK's MHRA has granted 47 new pharmaceutical manufacturing and wholesale dealer licences…

Eric Edwards, Pioneer of UK Kidney Transplantation, Dies

Eric Edwards, the pioneering British urologist who performed the first cadaver kidney…

UK Approves 47 New Pharmaceutical Manufacturing and Wholesale Dealer Licences in Latest MHRA Review

UK's MHRA has granted 47 new pharmaceutical manufacturing and wholesale dealer licences…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Labetalol

By
Prof. Giorgi Pkhakadze
02/06/2026

Metoprolol

By
Prof. Giorgi Pkhakadze
02/06/2026

Nebivolol

By
Prof. Giorgi Pkhakadze
02/06/2026

Carvedilol

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up